Interferon Patents

Since its inception, AMAR has worked to build an extensive patent portfolio for low-dose orally administered interferon. This portfolio consists of patents with claims that encompass method of use or treatment and composition of matter and manufacturing. AMAR believes that its patent protection will ensure its future commercial success within the field of low-dose orally administered interferon use. AMAR presently owns or licenses 5 issued US patents related to interferon. AMAR has vigorously enforced its patent position in the past, resulting in successful settlement. There are no current patent litigation proceedings involving AMAR.


U.S. PATENT NO: 5,846,526

ISSUE DATE: DECEMBER 8, 1998

TERMINATION DATE: DECEMBER 8, 2015

 

U.S. PATENT NO: 6,036,949

ISSUE DATE: MARCH 14, 2000

TERMINATION DATE: MARCH 5, 2018

 

U.S. PATENT NO: 6,372,218 B1

ISSUE DATE: APRIL 16, 2002

TERMINATION DATE: APRIL 16, 2019

 
 
Powered by Phoca Download
Copyright © 2017 Amarillo Biosciences. All Rights Reserved.
Built and hosted by Dark Roast Hosting